Company Filing History:
Years Active: 2014
Title: Innovations of Feng-Qiao Li in Calcineurin Modulation
Introduction
Feng-Qiao Li is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of calcineurin activity. His work has implications for treating various neurological disorders.
Latest Patents
Feng-Qiao Li holds a patent titled "Methods of inhibiting calcineurin with ApoE analogs." This invention provides a method of modulating calcineurin activity in a cell by contacting the cell with at least one ApoE analog. The patent also discloses methods for treating disorders associated with calcineurin activity using one or more ApoE analogs. Notably, it offers a method for reducing demyelination and promoting remyelination in a subject. Additionally, the invention describes methods for treating spinal cord or nerve injury in a subject.
Career Highlights
Feng-Qiao Li is associated with Cognosci, Incorporated, where he continues to advance his research and innovations. His work is pivotal in exploring new therapeutic avenues for conditions linked to calcineurin activity.
Collaborations
Feng-Qiao Li collaborates with Michael Peter Vitek, contributing to the advancement of their shared research interests.
Conclusion
Feng-Qiao Li's innovative work in calcineurin modulation represents a significant step forward in the treatment of neurological disorders. His contributions are expected to have a lasting impact on the field of biomedical research.